Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer

Julia DiGiovanni; Marko Popovic; Edward Chow; David Cella; Jennifer L. Beaumont; Jasmine Nguyen; Dominic Chu; Anthony Adili; Natalie Pulenzas; Breanne Lechner; Henry Lam; Andrew Bottomley

Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer

Julia DiGiovanni, Marko Popovic, Edward Chow^*, David Cella, Jennifer L. Beaumont, Jasmine Nguyen, Dominic Chu, Anthony Adili, Natalie Pulenzas, Breanne Lechner, Henry Lam, Andrew Bottomley

^*Corresponding author for this work

Medical Social Sciences

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

This review aimed to compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQ-LC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQLC13 is clinically valid and useful. Conversely, the FACTL assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACTL was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

Original language	English (US)
Pages (from-to)	103-113
Number of pages	11
Journal	Journal of Pain Management
Volume	8
Issue number	2
State	Published - Sep 1 2015

Keywords

EORTC QLQ-C30
EORTC QLQ-LC13
FACT-G
FACT-L
Lung cancer
Oncology
Quality of Life

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c6224f382d8842848e4d61e8ea495671,

title = "Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer",

abstract = "This review aimed to compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQ-LC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQLC13 is clinically valid and useful. Conversely, the FACTL assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACTL was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.",

keywords = "EORTC QLQ-C30, EORTC QLQ-LC13, FACT-G, FACT-L, Lung cancer, Oncology, Quality of Life",

author = "Julia DiGiovanni and Marko Popovic and Edward Chow and David Cella and Beaumont, {Jennifer L.} and Jasmine Nguyen and Dominic Chu and Anthony Adili and Natalie Pulenzas and Breanne Lechner and Henry Lam and Andrew Bottomley",

note = "Publisher Copyright: {\textcopyright} Nova Science Publishers, Inc.",

year = "2015",

month = sep,

day = "1",

language = "English (US)",

volume = "8",

pages = "103--113",

journal = "Journal of Pain Management",

issn = "1939-5914",

publisher = "Nova Science Publishers, Inc.",

number = "2",

}

TY - JOUR

T1 - Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer

AU - DiGiovanni, Julia

AU - Popovic, Marko

AU - Chow, Edward

AU - Cella, David

AU - Beaumont, Jennifer L.

AU - Nguyen, Jasmine

AU - Chu, Dominic

AU - Adili, Anthony

AU - Pulenzas, Natalie

AU - Lechner, Breanne

AU - Lam, Henry

AU - Bottomley, Andrew

N1 - Publisher Copyright: © Nova Science Publishers, Inc.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - This review aimed to compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQ-LC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQLC13 is clinically valid and useful. Conversely, the FACTL assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACTL was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

AB - This review aimed to compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQ-LC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQLC13 is clinically valid and useful. Conversely, the FACTL assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACTL was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

KW - EORTC QLQ-C30

KW - EORTC QLQ-LC13

KW - FACT-G

KW - FACT-L

KW - Lung cancer

KW - Oncology

KW - Quality of Life

UR - http://www.scopus.com/inward/record.url?scp=84943248447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943248447&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84943248447

SN - 1939-5914

VL - 8

SP - 103

EP - 113

JO - Journal of Pain Management

JF - Journal of Pain Management

IS - 2

ER -

Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this